Drug recall · April 22, 2020
Levetiracetam Tablets USP 750 mg recall
Why: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, NDC 65862-247-08
- Lots / codes
Lot #: 24719001A1, Exp. Date 03/2021
- Quantity
- 8040 units
- Company
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Distribution
- Nationwide within the United States
- Initiated
- March 18, 2020 · Voluntary: Firm initiated
- Classified
- April 13, 2020
- Reported
- April 22, 2020
- Ended
- March 25, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levetiracetam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.